Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Asthma drug may shield newborn kidneys from cooling therapy damage

NCT ID NCT05853601

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times

Summary

This study tests whether giving theophylline, a drug used for asthma, soon after birth can prevent kidney injury in newborns with HIE (a lack of oxygen to the brain) who are treated with cooling therapy. About 30 infants will receive the drug to see if it is safe and to plan a larger trial. The goal is to reduce kidney damage, which can lead to longer hospital stays and higher death rates.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Oklahoma Health Sciences Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.